| Oct 31 |
MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors
|
| Oct 9 |
MiNK Therapeutics Inc (INKT) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
| Oct 8 |
MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors
|
| Oct 4 |
MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024
|
| Jun 5 |
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
|
| May 22 |
MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
|
| May 14 |
MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript
|
| May 14 |
MiNK Therapeutics reports Q1 results
|
| May 14 |
MiNK Reports First Quarter 2024 Results
|
| May 13 |
Why MiNK Therapeutics Stock Is Up 11% Monday
|
